Cardlytics, Inc.
CDLXNASDAQCommunication Services● Active
$5.98
+$5.37(+880.82%)
Market Cap$344712509
P/E Ratio—
52W High$5.984
52W Low$0.55
Cardlytics, Inc. (CDLX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CDLX · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.23B | $0.28B | $0.31B | $0.30B | $0.27B |
| Cost of Revenue | $0.13B | $0.16B | $0.18B | $0.19B | $0.16B |
| Gross Profit | $0.11B | $0.12B | $0.13B | $0.11B | $0.10B |
| Gross Margin %(computed) | 45.05% | 43.44% | 42.17% | 37.73% | 38.69% |
| Operating Expenses | |||||
| R&D Expenses | $0.04B | $0.05B | $0.05B | $0.05B | $0.04B |
| G&A Expenses | $0.05B | $0.07B | $0.06B | $0.08B | $0.07B |
| Total Operating Expenses | $0.15B | $0.32B | $0.27B | $0.57B | $0.23B |
| Operating Income | ($0.05B) | ($0.20B) | ($0.14B) | ($0.46B) | ($0.12B) |
| Operating Margin %(computed) | -20.21% | -70.25% | -43.88% | -153.34% | -45.90% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.00B | $0.01B |
| Income Before Tax | ($0.10B) | ($0.19B) | ($0.13B) | ($0.47B) | ($0.14B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.01B) |
| Net Income | ($0.10B) | ($0.19B) | ($0.13B) | ($0.47B) | ($0.13B) |
| Net Margin %(computed) | -44.36% | -68.02% | -43.56% | -155.85% | -48.13% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.95 | $-3.91 | $-3.69 | $-13.92 | $-3.99 |
| Wtd Avg Shares | 0.05B | 0.05B | 0.04B | 0.03B | 0.03B |
| EBITDA | ($0.02B) | ($0.15B) | ($0.10B) | ($0.42B) | ($0.09B) |
| EBITDA Margin %(computed) | -8.46% | -54.81% | -32.02% | -140.82% | -33.02% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Cardlytics, Inc. data
About Cardlytics, Inc. (CDLX) Income Statement
Cardlytics, Inc. (CDLX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CDLX reported revenue of $0.23B, gross profit of $0.11B (gross margin 45.05%), and net income of ($0.10B) — a net profit margin of -44.36%.
Frequently asked questions
CDLX · 4 questionsCardlytics, Inc. (CDLX) reported revenue of $0.23B for 2025, down 16.2% year-over-year.
CDLX revenueCDLX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08